Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 857456, 9 pages
http://dx.doi.org/10.1155/2014/857456
Research Article

Treatment of Rheumatoid Arthritis with Marine and Botanical Oils: An 18-Month, Randomized, and Double-Blind Trial

1University of Massachusetts Medical School, Department of Medicine, Division of Preventive and Behavioral Medicine, 55 Lake Avenue North, Shaw Building, Worcester, MA 01655, USA
2University of Massachusetts Medical School, Department of Medicine, Rheumatology Division, 55 Lake Avenue North, LRB 240, Worcester, MA 01655, USA
3University of Massachusetts Medical School, Department of Family Medicine and Community Health, 55 Lake Avenue North, Benedict Building A3-214, Worcester, MA 01655, USA
4University of Washington School of Medicine, Bainbridge Island, Seattle, WA, USA
5University of Massachusetts Medical School, Department of Medicine, Rheumatology Division, 55 Lake Avenue North, LRB 840D, Worcester, MA 01655, USA

Received 8 November 2013; Accepted 10 February 2014; Published 19 March 2014

Academic Editor: José Luis Ríos

Copyright © 2014 George W. Reed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Zurier, “Prostaglandins, leukotrienes and related compounds,” in Kelley's Textbook of Rheumatology, G. S. Firestein, R. C. Budd, T. Harris, I. B. McIness, S. Ruddy, and J. S. Sergent, Eds., pp. 343–356, Elsevier Saunders, Philadelphia, Pa, USA, 8th edition, 2009. View at Google Scholar
  2. J. A. Boyce, “Eicosanoids in asthma, allergic inflammation, and host defense,” Current Molecular Medicine, vol. 8, no. 5, pp. 335–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Peters-Golden, “Expanding roles for leukotrienes in airway inflammation,” Current Allergy and Asthma Reports, vol. 8, no. 4, pp. 367–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. N. Serhan, N. Chiang, and T. E. van Dyke, “Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators,” Nature Reviews Immunology, vol. 8, no. 5, pp. 349–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Yaqoob and P. C. Calder, “Fatty acids and immune function: new insights into mechanisms,” British Journal of Nutrition, vol. 98, no. 1, pp. S41–S45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. S. Firestein, “Immunologic mechanisms in the pathogenesis of rheumatoid arthritis,” Journal of Clinical Rheumatology, vol. 11, no. 3, pp. S39–S44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Zurier, “Prostaglandin E1: is it useful?” The Journal of Rheumatology, vol. 17, no. 11, pp. 1439–1441, 1990. View at Google Scholar · View at Scopus
  8. V. A. Ziboh, C. C. Miller, and Y. Cho, “Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology,” Prostaglandins and Other Lipid Mediators, vol. 63, no. 1-2, pp. 3–13, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. DeMarco, D. Santoli, and R. B. Zurier, “Effects of fatty acids on proliferation and activation of human synovial compartment lymphocytes,” Journal of Leukocyte Biology, vol. 56, no. 5, pp. 612–615, 1994. View at Google Scholar · View at Scopus
  10. G. Tate, B. F. Mandell, M. Laposata et al., “Suppression of acute and chronic inflammation by dietary gamma linolenic acid,” The Journal of Rheumatology, vol. 16, no. 6, pp. 729–734, 1989. View at Google Scholar · View at Scopus
  11. Y.-Y. Fan and R. S. Chapkin, “Importance of dietary γ-linolenic acid in human health and nutrition,” Journal of Nutrition, vol. 128, no. 9, pp. 1411–1414, 1998. View at Google Scholar · View at Scopus
  12. R. B. Zurier, J. M. Kremer, and B. V. Basel, “Switzerland. Gammalinolenic acid treatment of rheumatoid arthritis,” in Medicinal Fatty Acids in Inflammation, J. M. Kremer, Ed., pp. 29–43, 1998. View at Google Scholar
  13. J. J. F. Belch and A. Hill, “Evening primrose oil and borage oil in rheumatologic conditions,” The American Journal of Clinical Nutrition, vol. 71, supplement 1, pp. 352S–356S, 2000. View at Google Scholar · View at Scopus
  14. J. M. Kremer, “n-3 fatty acid supplements in rheumatoid arthritis,” The American Journal of Clinical Nutrition, vol. 71, supplement 1, pp. 349S–351S, 2000. View at Google Scholar · View at Scopus
  15. P. C. Calder, “n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases,” The American Journal of Clinical Nutrition, vol. 83, no. 6, supplement, pp. 1505S–1519S, 2006. View at Google Scholar · View at Scopus
  16. G. A. Tate, B. F. Mandell, R. A. Karmali et al., “Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gammalinolenic acid and eicosapentaenoic acid,” Arthritis and Rheumatism, vol. 31, no. 12, pp. 1543–1551, 1988, Erratum in Arthritis and Rheumatism, vol. 33, no. 7, pp. 1042–1046, 1990. View at Google Scholar
  17. L. J. Leventhal, E. G. Boyce, and R. B. Zurier, “Treatment of rheumatoid arthritis with blackcurrant seed oil,” British Journal of Rheumatology, vol. 33, no. 9, pp. 847–852, 1994. View at Google Scholar · View at Scopus
  18. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  19. D. T. Felson, J. J. Anderson, M. Boers et al., “The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials,” Arthritis and Rheumatism, vol. 36, no. 6, pp. 729–740, 1993. View at Google Scholar · View at Scopus
  20. M. L. L. Prevoo, M. A. Van't Hof, H. H. Kuper, M. A. Leeuwen, L. B. A. Putte, and P. L. C. M. Riel, “Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 44–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. D. T. Felson, J. J. Anderson, M. Boers et al., “American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 6, pp. 727–735, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Aletaha, V. Nell, T. Stamm et al., “Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score,” Arthritis Research & Therapy, vol. 7, no. 4, pp. R796–R806, 2005. View at Google Scholar · View at Scopus
  23. J. Greenberg, L. Harrold, M. Bentley, J. Kremer, G. Reed, and V. Strand, “Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis,” Rheumatology, vol. 48, no. 6, pp. 686–690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. T. Sharp, M. D. Lidsky, L. C. Collins, and J. Moreland, “Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities,” Arthritis and Rheumatism, vol. 14, no. 6, pp. 706–720, 1971. View at Google Scholar · View at Scopus
  25. H. E. Paulus, M. S. Oh, J. T. Sharp et al., “Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1083–1096, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Cleveland, Visualizing Data, Hobart, 1993.
  27. P. Royston, “Multiple imputation of missing values: update of ice,” The Stata Journal, vol. 5, no. 4, pp. 227–241, 2004. View at Google Scholar · View at Scopus
  28. K. J. Lee and J. B. Carlin, “Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation,” American Journal of Epidemiology, vol. 171, no. 5, pp. 624–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Royston, J. B. Carlin, and I. R. White, “Multiple imputation of missing values: new features for mim,” Stata Journal, vol. 9, no. 2, pp. 252–264, 2009. View at Google Scholar · View at Scopus
  30. J. M. Kremer, “The CORRONA database,” Autoimmunity Reviews, vol. 5, no. 1, pp. 46–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Kremer, D. A. Lawrence, W. Jubiz et al., “Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects,” Arthritis and Rheumatism, vol. 33, no. 6, pp. 810–820, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. R. B. Zurier, R. Rossetti, E. Jacobson et al., “Gamma-linolenic acid treatment of rheumatoid arthritis: a randomized, placebo-controlled trial,” Arthritis and Rheumatism, vol. 39, no. 11, pp. 1808–1817, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Baker, K. Krakauer, G. Tate, M. Laposata, and R. B. Zurier, “Suppression of human synovial cell proliferation by dihomo-γ-linolenic acid,” Arthritis and Rheumatism, vol. 32, no. 10, pp. 1273–1281, 1989. View at Google Scholar · View at Scopus
  34. J. Bathon, R. Martin, R. Fleischmann et al., “A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis,” New England Journal of Medicine, vol. 343, no. 22, pp. 1586–1593, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Chilton, L. Rudel, J. Parks, J. Arm, and M. Seeds, “Mechanisms by which botanical lipids affect inflammatory disorders,” The American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 498S–503S, 2008. View at Google Scholar · View at Scopus
  36. N. J. Olsen, “Tailoring arthritis therapy in the wake of the NSAID crisis,” New England Journal of Medicine, vol. 352, no. 25, pp. 2578–2580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Yu, E. Ricciotti, T. Grosser, and G. Fitzgerald, “The translational therapeutics of prostaglandin inhibition in atherothrombosis,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 222–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. L. G. Cleland, G. E. Caughey, M. J. James, and S. M. Proudmam, “Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis,” The Journal of Rheumatology, vol. 33, no. 10, pp. 1973–1979, 2006. View at Google Scholar · View at Scopus
  39. B. C. Olendzki, K. Leung, S. van Buskirk, G. Reed, and R. B. Zurier, “Treatment of rheumatoid arthritis with marine and botanical oils: Influence on serum lipids,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 827286, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus